Serum Institute will manufacture an experimental tuberculosis vaccine. This novel vaccine candidate is currently in late-stage clinical trials. Gates Medical Research Institute will transfer manufacturing technology and know-how. The company plans to invest over one hundred million dollars for production. This new shot could prevent millions of cases and save lives.